CAR T-Cell Therapy for Patients With CLL/SLL: TRANSCEND CLL 004
Posted: 09/06/2023 | By: Chase Doyle

In a study published by Siddiqi et al in The Lancet, researchers evaluated the efficacy and safety of lisocabtagene maraleucel in patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

Question 1 of 5

Who were the participants in the TRANSCEND CLL 004 study?

Choose 1